Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Fourth Quarter, 1999 - Quarterly Biosafety Listings - Office of Laboratory Security

Quarterly Biosafety Listings


Fourth Quarter, 1999


Cities need new drugs, diagnostic tests, and software to prepare for chemical, biological attacks [news]. Public Health Rep 1999;114:106.

Drugs and vaccines against biological weapons. Med Lett Drugs Ther 1999;41:15-6.

Agolini G, Russo A, Clementi M. Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity. Am J Infect Control 1999;27:236-39.

Ahlstrom B, Thompson RA, Edebo L. Loss of bactericidal capacity of long-chain quaternary ammonium compounds with protein at lowered temperature. Apmis 1999;107:606-14.

Alper J. From the bioweapons trenches, new tools for battling microbes [news]. Science 1999;284:1754-55.

Amdekar YK. Multidrug resistant tuberculosis [editorial]. Indian Pediatr 1998;35:715-18.

Armstrong LR, Dembry LM, Rainey PM, Russi MB, Khan AS, Fischer SH, Edberg SC, Ksiazek TG, Rollin PE, Peters CJ. Management of a Sabia virus-infected patients in a US hospital. Infect Control Hosp Epidemiol 1999;20:176-82.

Atlas RM. The threat of bioterrorism returns the fear of smallpox. Curr Opin Microbiol 1998;1:719-21.

Bettner MD, Beiswanger MA, Miller CH, Palenik CJ. Effect of ultrasonic cleaning on microorganisms. Am J Dent 1998;11:185-88.

Blydt HT, Subbarao K, Quennec P, McDonald J. Recovery of respiratory syncytial virus from stethoscopes by conventional viral culture and polymerase chain reaction. Pediatr Infect Dis J 1999;18:164-65.

Cardoso CL, Pereira HH, Zequim JC, Guilhermetti M. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Amer J Infect Control 1999;27:327-31.

Chanzy B, Duebin DL, Rousset B, Morand P, Morelbaccard C, Marchetti B, Fauconnier J, Mallaret MR, Calop J, Zarski JP et al. Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endoscop 1999;50:147-51.

Cureton SL, Best NH, Runyan DA. Disinfection of permanent markers. J Clin Orthod  1996;30:646-49.

Dukan S, Belkin S, Touati D. Reactive oxygen species are partially involved in the bacteriocidal action of hypochlorous acid. Arch Biochem Biophys 1999;367:311-16.

Eitzen-EM J. Education is the key to defense against bioterrorism [editorial]. Ann Emerg Med 1999;34:221-23.

Fabris P, Manfrin V, Rassu M, Tositti G, de-Lalla F, Zanetti A. Triple therapy prevents HIV but not HCV transmission after needlestick injury [letter]. Am J Gastroenterol 1999;94:1990-91.

Fox JL. Adjusting FDA policies to address bioterrorist threat [news]. Nat Biotechnol 1999;17:323-24.

Gutierrez CB, Alvarez D, Rodriguez BJ, Tascon RI, de lP, V, Rodriguez FE. In vitro efficacy of N-duopropenide, a recently developed disinfectant containing quaternary ammonium compounds, against selected gram-positive and gram-negative organisms. Am J Vet Res 1999;60:481-84.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281:2127-37.

Henderson DA. Others should follow the US line on bioweapons [letter]. Nature 1999;399:632.

Hurwitz JJ, Fine N, Rachlis AR. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group. Can J Ophthalmol 1999;34:195-203.

Janacek K, Lodin Z. [Determination of chlorine levels in Presept, a modern disinfectant]. Epidemiol Mikrobiol Imunol 1999;48:63-6.

Johnson KM. Gleanings from the harvest: suggestions for priority actions against Ebola virus epidemics. J Infect Dis 1999;179(Suppl 1):S287-S88.

Jones RD. Bacterial resistance and topical antimicrobial wash products. Amer J Infect Control 1999;27:351-63.

Kampf G, Hofer M, Wendt C. Efficacy of hand disinfectants against vancomycin-resistant enterococci in vitro. J Hosp Infect 1999;42:143-50.

Mervis J. Emerging diseases. Canada dedicates new human, animal labs [news]. Science 1999;284:1902.

Meyer B, Kluin C. Efficacy of Glucoprotamin containing disinfectants against different species of atypical mycobacteria. J Hosp Infect 1999;42:151-54.

Miner N. Principles to guide international standard tests for liquid chemical germicides: a proposal. J AOAC Int 1999;82:669-75.

Moran GJ. Update on emerging infections from the Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998. Ann Emerg Med 1999;34:229-32.

Nass M. Anthrax vaccine. Model of a response to the biologic warfare threat. Infect Dis Clin North Am 1999;13:187-208,viii.

Neely AN, Maley MP. Another disinfectant for enterococci. Infect Control Hosp Epidemiol 1999;20:388-89.

Oie S, Kamiya A, Tomita M, Katayama A, Iwasaki A, Miyamura S. Efficacy of disinfectants and heat against Escherichia coli O157:H7. Microbios 1999;98:7-14.

Osborne R, Durkin T, Shannon H, Dornan E, Hughes C. Performance of open-fronted microbiological safety cabinets: the value of operator protection tests during routine servicing. J Appl Microbiol 1999;86:962-70.

Peltroche LH, Haase G, Lutticken R. [Methicillin-resistant Staphylococcus aureus (MRSA) - clinical implications]. Chirurg 1998;69:801-05.

Perry PA. Needle safety. Unstuck in California [news]. Hosp Health Netw 1999;73:16,18.

Pitten FA, Muller P, Heeg P, Kramer A. [The efficacy of repeated disinfection of disposable gloves during usage]. Zentralbl Hyg Umweltmed 1999;201:555-62.

Price DL, Ahearn DG. Sanitation of wallboard colonized with Stachybotrys chartarum. Curr Microbiol 1999;39:21-6.

Renner P, Peters J. Resistance of enterococci to heat and chemical agents. Zbl Hyg Umweltmed 1999;202:41-50.

Reponen TA, Wang Z, Willeke K, Grinshpun SA. Survival of mycobacteria on N95 personal respirators. Infect Control Hosp Epidemiol 1999;20:237-41.

Richards CF, Burstein JL, Waeckerle JF, Hutson HR. Emergency physicians and biological terrorism. Ann Emerg Med 1999;34:183-90.

Russell AD, Suller MTE, Maillard JY. Do antiseptics and disinfectants select for antibiotic resistance? J Med Microbiol 1999;48:613-15.

Shibuya A, Takeuchi A, Sakurai K, Saigenji K. Hepatitis G virus infection from needle-stick injuries in hospital employees. J Hosp Infect 1998;40:287-90.

Stanley PM. Efficacy of peroxygen compounds against glutaraldehyde-resistant mycobacteria. Amer J Infect Control 1999;27:339-43.

Steelman VM. Prion diseases - an evidence-based protocol for infection control. AORN J 1999;69:946-67.

Stine R. How effective is your surface disinfectant. Tex Dent J 1999;116:82-4.

Suchard J. Biological warfare [letter]. West J Med 1999;170:243.

Tilt N, Hamilton MA. Repeatability and reproducibility of germicide tests: a literature review. J AOAC Int 1999;82:384-89.

Udou T. [Emergence of new-risk factors associated with nosocominal infection]. Sangyo Ika Daigaku Zasshi 1998;20:361-68.

Wadman M. Scientists split on US smallpox decision [news]. Nature 1999;398:741.

Walsh SE, Maillard JY, Russell AD. Ortho-phthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 1999;86:1039-46.

Widmer AF. [The end of handwashing: to the next millennium with hygienic disinfection of hands]. Schweiz Rundsch Med Prax 1999;88:761-63.

Wilson JA, Margolin AB. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts. J Hosp Infect 1999;42:231-37.

© 1999 Health Canada

[Office of Laboratory Security] [Quarterly Biosafety Listings]